Cargando…
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
Autores principales: | Schilling, William H.K., Bancone, Germana, White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413154/ https://www.ncbi.nlm.nih.gov/pubmed/32836191 http://dx.doi.org/10.1016/j.bcmd.2020.102484 |
Ejemplares similares
-
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018) -
“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
por: Sgherza, Nicola, et al.
Publicado: (2020) -
Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study
por: Obeidat, Khaldun, et al.
Publicado: (2020) -
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021) -
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
por: Anderle, Athena, et al.
Publicado: (2018)